Defined Culture Medium for Retinal Progenitor Cell Expansion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating retinal progenitor cells from human induced pluripotent stem cells face challenges in scaling up production while maintaining their proliferative capacity and retinal multipotency, which is crucial for therapeutic applications and drug screening.
Innovation Solution
A defined cell culture medium comprising a nutrient medium, an SHH-pathway activator, and a GSK3 inhibitor is used to expand human retinal progenitor cells, ensuring their mitotic capacity and retinal multipotency, allowing for large-scale production of cells suitable for transplantation and drug screening.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If conventional methods are used to generate retinal progenitor cells from hiPSCs, then the cells can be produced, but the production quantity is insufficient for clinical applications
Solution Approach 1:
The patent changes the chemical parameters of the culture medium by adding specific small molecules (CHIR99021 at 3 μM and purmorphamine at 1 μM) to the nutrient medium. This parameter modification enables the culture medium to maintain retinal multipotency and mitotic capacity during cell expansion, thereby increasing both the quantity and productivity of retinal progenitor cells for clinical applications
2Quantity of substance
If retinal progenitor cells are expanded in culture, then the cell quantity increases, but the mitotic capacity and retinal multipotency are lost
Solution Approach 1:
The patent implements continuous maintenance of retinal multipotency and mitotic capacity throughout the cell expansion process by continuously providing the optimized culture medium containing CHIR99021 and purmorphamine. This continuous action ensures that even after multiple passages (up to 10 passages), the cells retain their therapeutic quality and functional properties while achieving high cell quantities
Solution Approach 2:
The culture medium formulation incorporates specific signaling pathway modulators that create a feedback mechanism to maintain retinal progenitor characteristics. The GSK3 inhibitor (CHIR99021) and SHH pathway activator (purmorphamine) work together to sustain mitotic capacity and retinal multipotency signals throughout the expansion process, ensuring cells remain suitable for transplantation
3Ease of manufacture
If the production protocol is simplified for clinical use, then the ease of manufacture improves, but the ability to maintain cell quality during expansion deteriorates
Solution Approach 1:
The patent extracts and eliminates complex steps from conventional protocols, such as removing the need for embryoid body formation, exogenous molecule coatings, and substrate preparations. The simplified protocol uses only a defined nutrient medium with two small molecules, making the manufacturing process easier while maintaining cell quality through the specific chemical composition
Data Source
AI summary
The disclosure pertains to a defined cell culture medium for the expansion of human retinal progenitors, comprising or consisting of a nutrient medium, a SHH-pathway activator and a GSK3 inhibitor. To the use of the defined cell culture medium for the expansion of retinal progenitors, as well as to an in vitro method for expanding retinal progenitors, comprising: (i) placing a culture of human retinal progenitors in a defined cell culture medium as defined in claims 1 to 8; and (ii) culturing the cells in said defined cell culture medium.